Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$567M |
| 2 |
Kroger
KR
|
+$566M |
| 3 |
AGN
Allergan plc
AGN
|
+$491M |
| 4 |
NXP Semiconductors
NXPI
|
+$366M |
| 5 |
Sherwin-Williams
SHW
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$880M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$731M |
| 3 |
CELG
Celgene Corp
CELG
|
+$395M |
| 4 |
AGN
Allergan Inc
AGN
|
+$320M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Technology | 12.89% |
| 4 | Communication Services | 12.45% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
401
Summit Hotel Properties
INN
$748M
| $30.1M | 0.03% |
2,140,672
-694,118
| -24% | -$9.23M |
|
402
Flotek Industries
FTK
$847M
| $29.5M | 0.03% |
333,671
+2,071
| +0.6% | +$202K |
|
|
TVTY
403
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $28.5M | 0.03% |
1,448,937
-28,595
| -2% | -$598K |
|
|
SPNC
404
DELISTED
Spectranetics Corp
SPNC
| $28.3M | 0.03% |
814,925
+558,469
| +218% | +$19M |
|
405
Lowe's Companies
LOW
$118B
| $27.9M | 0.03% |
+374,872
| New | +$26.9M |
|
|
GWPH
406
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27.7M | 0.03% |
304,196
+45,282
| +17% | +$3.68M |
|
|
CMO
407
DELISTED
Capstead Mortgage Corp.
CMO
| $27.2M | 0.02% |
2,311,845
-35,523
| -2% | -$427K |
|
|
SGMO
408
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $26.9M | 0.02% |
1,717,922
+4,273
| +0.2% | +$66.1K |
|
409
UnitedHealth
UNH
$383B
| $26.9M | 0.02% |
227,435
+704
| +0.3% | +$78.2K |
|
|
DYN.PRA
410
DELISTED
Dynegy Inc.
DYN.PRA
| $26.6M | 0.02% |
244,031
+1,084
| +0.4% | +$113K |
|
411
BOK Financial
BOKF
$8.57B
| $26.5M | 0.02% |
432,468
-8,040
| -2% | -$469K |
|
412
Assembly Biosciences
ASMB
$516M
| $26.4M | 0.02% |
166,327
+91,834
| +123% | +$12.4M |
|
|
LPNT
413
DELISTED
LifePoint Health, Inc.
LPNT
| $26M | 0.02% |
353,615
-7,623
| -2% | -$541K |
|
|
PFPT
414
DELISTED
Proofpoint, Inc.
PFPT
| $25.7M | 0.02% |
433,694
-9,296
| -2% | -$500K |
|
|
ARUN
415
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $25.7M | 0.02% |
+1,048,619
| New | +$21.1M |
|
416
Monolithic Power Systems
MPWR
$64.7B
| $25.6M | 0.02% |
485,281
+1,562
| +0.3% | +$78.7K |
|
417
Freeport-McMoran
FCX
$91.2B
| $25.5M | 0.02% |
1,347,958
+21,247
| +2% | +$420K |
|
418
Core Laboratories
CLB
$477M
| $25.5M | 0.02% |
244,035
-308,804
| -56% | -$32.9M |
|
|
CSII
419
DELISTED
Cardiovascular Systems, Inc.
CSII
| $25.3M | 0.02% |
648,290
-13,313
| -2% | -$459K |
|
420
Plains GP Holdings
PAGP
$5.26B
| $24.8M | 0.02% |
328,896
+18,633
| +6% | +$1.35M |
|
|
MDCO
421
DELISTED
Medicines Co
MDCO
| $24.8M | 0.02% |
883,310
+2,826
| +0.3% | +$79.4K |
|
422
Atara Biotherapeutics
ATRA
$73.6M
| $24.7M | 0.02% |
23,790
+12,042
| +103% | +$7.96M |
|
423
B2Gold
BTG
$5.13B
| $24.5M | 0.02% |
16,461,917
+101,912
| +0.6% | +$179K |
|
|
PTLA
424
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.4M | 0.02% |
643,357
+2,058
| +0.3% | +$70.7K |
|
425
Provident Financial Services
PFS
$3.24B
| $24.4M | 0.02% |
1,308,691
+1,122,468
| +603% | +$20.3M |
|
Similar funds
Jennison Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Jennison Associates held 801 positions worth $109B, up 2.1% from $107B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q1 2015 filing shows 86 new, 297 increased, 319 reduced and 92 closed positions. Its largest new stake was NXP Semiconductors: 4,151,977 shares worth $417M. The largest sale was PRECISION CASTPARTS CORP, an estimated $880M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q1 2015 buy was NXP Semiconductors: 4,151,977 shares worth $417M.
- Jennison Associates added most to Time Warner Inc in Q1 2015, an estimated $567M increase.
- Jennison Associates's biggest Q1 2015 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $731M.
- Jennison Associates fully exited PRECISION CASTPARTS CORP in Q1 2015, selling an estimated $880M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q1 2015.
- Jennison Associates opened 86 new positions and closed 92 in Q1 2015.
- Jennison Associates's portfolio value rose 2.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.